Felix Beuschlein announced as winner of 2024 Transatlantic Alliance Award in Endocrinology

(Press-News.org) Felix Beuschlein is Professor of Internal Medicine/Endocrinology and Director of the Clinic for Endocrinology, Diabetology and Clinical Nutrition at the University Clinic Zurich in Switzerland. He received his medical degree from School of Medicine at the University of Würzburg and completed his medical training in Freiburg, both in Germany. For postdoctoral studies he joined the University of Michigan in Ann Arbor. Following a professorship for Endocrine Research at the University of Munich, he was elected for a chair position at the University of Zurich in 2017.  

The Transatlantic Alliance Award, which was launched in 2021, recognises an international leader who has made significant advancements in endocrine research on both sides of the Atlantic - in Europe and the United States. 

Professor Beuschlein has received this prestigious Award in recognition of his transformational endocrine research and the impact of this research in the field of adrenal tumours. Through his collaborative approach across the European Network for the Study of Adrenal Tumors (ENS@T) with colleagues from the American Australasian Asian Adrenal Alliance (A5), he has fostered the transformation of knowledge and understanding of adrenal tumours and unlocked true transatlantic collaboration. 

“Felix Beuschlein has been instrumental in driving research forward in the adrenal tumour field and he has demonstrated what can be achieved when collaborating with colleagues across Europe and across the Atlantic.” said ESE President Professor Jérôme Bertherat. He added, “We are delighted to recognise his sizable contribution to endocrinology and the many committees he has been involved with.” 

“This Award honors Felix Beuschlein’s excellence in leadership, his lifetime achievement in teaching and research, and his outstanding contributions to the field of endocrinology,” said Endocrine Society President Stephen Hammes, M.D., Ph.D. “in addition to his dedication to advancing adrenal tumour research, Dr. Beuschlein has paved the way for international exchange between fellow endocrine researchers and clinicians both as the chair of our annual meeting in 2021, and as an associate editor of our flagship clinical research journal, the Journal of Clinical Endocrinology & Metabolism. He is truly a worthy recipient of this award.”   

Professor Beuschlein’s scientific interests mainly relate to adrenal disorders and endocrine tumours. He has authored more than 460 publications in high-ranking international journals and has received many awards, including the European Journal of Endocrinology Prize and the Society for Endocrinology (UK) European Medal. He has organised several scientific meetings and has co-chaired the program organising committee for a European Congress of Endocrinology (ECE) meeting and served as head of the annual meeting steering committee of the ENDO 2021 meeting. As a strong believer in the value of scientific and clinical networking, Felix has been involved in numerous national and international approaches, including coordination of the ENS@T-CANCER Consortium and participation in a number of European and international programmes. 
 
He has served on several boards including the Annual Meeting Steering Committee of the Endocrine Society, the Executive Committee of the Swiss Endocrine Society and has been the vice president of the German Endocrine Society. He has been a founding member, Steering Committee member and chairman of ENS@T. 

Professor Beuschlein commented “I am deeply moved to be this year's recipient of the Transatlantic Alliance Award. As a strong believer in the power of international collaborations, this award comes as a particular honour as it signifies the connection of the international endocrine community through science and clinical care. The award reflects also more than personal achievement but rather a broad array of dedicated individuals - mentors who have guided me, colleagues with whom I share the dedication in endocrine research, and the next generation of students and researchers who bring fresh perspectives and renewed energy. I am obliged to both societies and applaud their common spirit to pushing the frontiers of endocrinology for the betterment of patient care worldwide.” 

Professor Felix Beuschlein will present his award lecture at ECE, the 26th European Congress of Endocrinology, which will take place from 11-14 May 2024 in Stockholm, Sweden. He will also speak at the Endocrine Society’s annual meeting, ENDO 2024, which will take place from 1-4 June 2024 in Boston, MA, U.S.A.  

Nominations for the 2025 Transatlantic Alliance Award will open later this year. 

*** ENDS *** 

 

About the European Society of Endocrinology 

The European Society of Endocrinology (ESE) provides a platform to develop and share leading research and best knowledge in endocrine science and medicine. By uniting and representing every part of the endocrine community, we are best placed to improve the lives of patients. With over 5,000 individual members and through the 51 National Societies involved with the ESE Council of Affiliated Societies (ECAS) ESE represents a community of over 20,000 European endocrinologists. We inform policy makers on health decisions at the highest level through advocacy efforts across Europe.  

To find out more, please visit www.ese-hormones.org.   

Follow us on Twitter @ESEndocrinology, Facebook @EuropeanSocietyofEndocrinology and LinkedIn: linkedin.com/company/european-society-of-endocrinology.  

 

About the Endocrine Society  
Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions. 
 
The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia. 

 

 

 

END